Pharma marketing agency serving Prosper and Collin and Denton counties
Ichelon Consulting US runs HCP marketing, unbranded disease-awareness, patient-support enrollment and DTC campaigns for prescription-drug brand teams. Every asset is scoped against FDA promotional-labeling rules, DSCSA supply-chain integrity requirements, OIG-EIG anti-kickback boundaries and state prescription-drug advertising laws — because a fair-balance failure in a single social asset is a fast route to an untitled letter. We deliver against Prosper and its surrounding Collin and Denton counties footprint — an affluent North DFW town whose rapid residential growth has been matched by concentrated commercial development along Preston Road and the Dallas North Tollway, with a heavy skew toward specialty healthcare, boutique real estate and consumer-brand founders.
- Ichelon Consulting US runs pharmaceutical marketing for branded prescription and OTC teams, specialty-pharmacy manufacturers, generics companies and biosimilar launches headquartered in Prosper and across Collin and Denton counties, on the standard pharma delivery stack — feed, analytics, paid, organic, and reputation.
- FDA-scoped and OIG-EIG-aware from first campaign draft — every asset, every workflow, every audience list is scoped against FDA promotional-labeling rules, DSCSA supply-chain integrity requirements, OIG-EIG anti-kickback boundaries and state prescription-drug advertising laws.
- Location-aware delivery — Prosper campaigns run against realistic drive-time isochrones covering Frisco, Celina, McKinney and the the Preston Road and Dallas North Tollway corridor.
- Six-service delivery spine — the same six services below, adapted for the Prosper buyer, not a diluted regional package.
- Reporting rolls up by service line, by campaign, by location, and by revenue-relevant channel — not vanity engagement.
- Dallas, Texas LLC
- 10-person US client team · Central Time (CST)
- 25+ US healthcare clients
- BAA signed with every client
- HIPAA compliance training across client and delivery teams
- Contracts and invoices in USD
-
Primary Care · North Dallas, TXCase study →
-
MedSpa · North Dallas, TX
-
Skin Care · Beverly Hills, CA
-
Dental · Christiansburg, VACase study →
-
Pediatrics · Blacksburg, VACase study →
-
Pediatric Dentistry · Blacksburg, VACase study →
-
Dental · Roanoke, VACase study →
-
Functional Medicine · Telehealth · USACase study →
“They were able to get all my ideas and work with me over a period of three to four months and create this amazing website. It's super customized, very modern, and it incorporates all the elements that I had wanted — the patient portal, nice pictures, a very interactive website, patient reviews. I would highly recommend their company to anyone who wants to make an excellent website.”
A pharmaceutical marketing practice built for the Prosper footprint, not a generic regional package
Prosper sits inside one of the more distinctive commercial footprints in the United States — an affluent North DFW town whose rapid residential growth has been matched by concentrated commercial development along Preston Road and the Dallas North Tollway, with a heavy skew toward specialty healthcare, boutique real estate and consumer-brand founders. For a brand manager, HCP marketing lead, medical affairs partner, or commercial operations lead operating here, that means a buyer base that skews time-poor and research-heavy, a competitive set that has been ramping paid and organic investment for several quarters, and a compliance surface that is anything but generic: FDA promotional-labeling rules, DSCSA supply-chain integrity requirements, OIG-EIG anti-kickback boundaries and state prescription-drug advertising laws all show up in the audit trail whenever a campaign scales past a single-city footprint.
Ichelon Consulting US's pharmaceutical marketing practice is built for that reality. We deliver against the same six-service spine used for national clients — feed-and-analytics discipline, paid, organic, reputation, compliance-mapped disclosure libraries, and reporting that maps to revenue rather than vanity engagement. What changes for Prosper is the geo-fencing, the drive-time isochrones that respect the Preston Road and Dallas North Tollway corridor, the local competitive set, and the specific interpretation of Collin and Denton counties advertising norms that shows up in ad-platform disapproval patterns.
Every engagement is reviewed by senior pharmaceutical marketing operators across the ICG global footprint. A Prosper brand manager, HCP marketing lead, medical affairs partner, or commercial operations lead works with a reviewer who has scoped the same discipline for compliance frameworks that apply here, and who can pattern-match against similar accounts in adjacent regions. That transfer of pattern — from other North Texas cities like Frisco, Celina and McKinney, and from national accounts — is what keeps ramp-times short and disapproval rates low.
Six pharmaceutical marketing services tailored to Prosper operators
Pharma in Prosper is a discipline of feed, analytics, paid, organic, reputation and compliance. Get one wrong and a well-optimized campaign becomes a liability. The six-service spine below treats all six as core, not add-on — delivered against the same standards used for enterprise clients across the ICG global footprint.
1. HCP paid media and content
Endemic HCP channels, professional-society sponsorships and native content programs built against fair-balance requirements, with reviewer-approved copy libraries and version control that maps every asset back to its MLR-approved parent.
2. Unbranded disease-awareness campaigns
Non-branded educational campaigns scoped for FDA compliance on unbranded content, with clear separation from branded assets and audit trails that document intent, targeting and reach.
3. Patient-support program enrollment
Enrollment funnels for hub services, copay support, and adherence programs, with consent language and privacy notices that respect state prescription-drug laws and HIPAA-adjacent PHI handling.
4. Direct-to-consumer campaigns
Google, Meta and connected-TV DTC campaigns with fair-balance treatment inline with FDA requirements, adverse-event reporting hooks in every intake, and creative libraries versioned against MLR-approved masters.
5. Congress and conference activation
Pre-congress paid media, on-site experience design and post-congress nurture programs scoped against congress rules, PhRMA code, and OIG-EIG anti-kickback boundaries.
6. Medical affairs and KOL engagement content
Educational assets, KOL video programs and evidence-summary content produced against medical-legal-regulatory approval workflows, with structured content atoms that survive MLR revision cycles.
Practice serving Prosper and surrounding North Texas cities
Ichelon Consulting US works with branded prescription and OTC teams, specialty-pharmacy manufacturers, generics companies and biosimilar launches headquartered across Prosper and the broader Collin and Denton counties footprint — an affluent North DFW town whose rapid residential growth has been matched by concentrated commercial development along Preston Road and the Dallas North Tollway, with a heavy skew toward specialty healthcare, boutique real estate and consumer-brand founders. Delivery covers the surrounding neighborhoods below, all within the the Preston Road and Dallas North Tollway corridor.
Every Prosper pharmaceutical marketing campaign is scoped against these frameworks
Angryturtle · SIE · YODA
Pharma buying in Prosper happens across three surfaces — classical search for high-intent queries, AI Overview citations for comparison and research intent, and YouTube for long-consideration research. The Trifecta covers all three.
Angryturtle · GBP OS
Angryturtle deployed for regional medical liaisons and speaker-program geographies. Post cadence covers unbranded disease-awareness and MSL-visit availability.
SIE · Search Intelligence Engine
Topic map covering unbranded disease education, treatment-landscape intent and HCP resource intent. Briefs written against MLR-approved parent copy and audit-ready for FDA review.
YODA · YouTube AIO
Unbranded disease-awareness videos, HCP-facing evidence summaries and KOL programs on a curated cadence. All assets MLR-approved and adverse-event-reporting-linked.
Backed by ICG global leadership
Every Prosper engagement has direct line-of-sight to the ICG Leadership Team and to a senior pharmaceutical marketing reviewer. Leadership sits across Dallas, Delhi and Sydney, so a Prosper brand manager, HCP marketing lead, medical affairs partner, or commercial operations lead works with a reviewer who has scoped the same pharma discipline for the compliance frameworks that apply here.
Our own tools run inside every engagement
Ichelon Consulting US uses software built by our own product team. Practices can also use most tools on their own, billed in USD.
Pharma marketing in Prosper — common questions
Questions we hear from brand manager, HCP marketing lead, medical affairs partner, or commercial operations leads across Prosper and Collin and Denton counties.
Do you understand fair-balance requirements?
Yes. Every branded asset carries the risk information required by FDA promotional-labeling rules, with placement, font size, and presentation cadence matched to the medium. Copy libraries are versioned against MLR-approved masters.
How do you handle MLR review?
We work inside the client's MLR workflow — Veeva PromoMats, Aprimo, or a bespoke queue. Content atoms are structured so revisions do not force full re-approval. Approval trails export directly for FDA audit.
Can you support hub-services enrollment?
Yes. Enrollment funnels for hub services, copay assistance, and patient-adherence programs, with consent language and privacy notices scoped for state prescription-drug laws and the HIPAA-adjacent PHI handling that specialty pharmacy requires.
Do you run adverse-event reporting infrastructure?
Every intake and enrollment funnel carries an adverse-event reporting hook that routes reports to the client's PV vendor within FDA-required timelines. Field-level validation reduces false triggers.
How do you manage OIG-EIG anti-kickback boundaries?
Every HCP-facing program is reviewed against OIG-EIG anti-kickback rules and PhRMA code. Item and service exchanges are documented, fair-market-value analyses are on file, and no promotional program is offered as inducement for prescription or referral.
What is a typical pharma engagement cost?
Retainers are custom-scoped per engagement · from 9/month equivalent (approx USD 250 / AUD 370). National branded launches with complex MLR workflows scale up from there.
Scope your Prosper pharmaceutical marketing engagement with Ichelon Consulting US
Book a 30-minute benchmarking call with a member of the Leadership Team, email the US practice lead, or WhatsApp us in your time zone.
Related Ichelon Consulting US hubs
Healthcare brands ICG
has worked with.
A representative slice of the 150+ healthcare brands ICG has delivered for across India. Full client list available under NDA during a Brand and Growth Diagnostic.
